Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.

Publikation

Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.

Wissenschaftlicher Artikel/Review - 02.02.2022

Jakeman Bernadette, Scherrer Alexandra, Battegay Manuel, Günthard Huldrych F, Hachfeld Anna, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Marzolini Catia

Zitation

Jakeman B, Scherrer A, Battegay M, Günthard H, Hachfeld A, Calmy A, Schmid P, Bernasconi E, Cavassini M, Marzolini C. Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study. J Antimicrob Chemother 2022; 77:492-499.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

J Antimicrob Chemother 2022; 77

Veröffentlichungsdatum

02.02.2022

eISSN (Online)

1460-2091

Seiten

492-499

Kurzbeschreibung/Zielsetzung

Anticholinergic (ACH) medications have been associated with neurocognitive impairment, particularly in the elderly. This study determined prospectively the prevalence of prescribed ACH medications and their association with self-reported neurocognitive impairment (SRNI) in elderly people living with HIV (PLWH) of the Swiss HIV Cohort Study (SHCS).